Radhakrishnan Emphasizes Clinical Evidence for Heart Disease at Chennai Event

Speaking at the launch of the India Valve Registry, Vice President C.P. Radhakrishnan urged the medical community to prioritize the creation of India‑specific clinical evidence for heart disease. He argued that such data are vital for strengthening research, guiding therapeutic choices, and improving outcomes for patients across the country. The Vice President also called for inclusive, accessible progress in the medical sector through stronger partnerships among clinicians, scientists, and academic bodies.